GlassScriptPhysician profile
Kavneet Kaur
NPI 1003201195
$1,700.84
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $218 · 2021: $504 · 2022: $138 · 2023: $408 · 2024: $71.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $339.07 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $313.43 | 2021-2023 | Andexxa |
| Genentech USA, INC. | $252.88 | 2019 | |
| Alexion Pharmaceuticals, INC. | $187.73 | 2019-2022 | |
| Neurelis, INC. | $157.31 | 2021-2022 | |
| Medtronic Vascular, INC. | $125.04 | 2020 | |
| Biogen, INC. | $91.23 | 2021 | |
| Medtronic USA, INC. | $67.63 | 2020 | |
| Janssen Pharmaceuticals, INC | $40.23 | 2020-2021 | |
| Horizon Therapeutics Plc | $34.51 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.47 | 2021 | |
| Eisai INC. | $21.37 | 2024 | |
| Allergan, INC. | $17.62 | 2021 | |
| Steris Corporation | $15.78 | 2024 | |
| Pfizer INC. | $14.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kavneet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.